Marc Remke Selected Research

Medulloblastoma

1/2022	The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors.
1/2021	Expression of cell type incongruent alpha-cardiac actin 1 subunit in medulloblastoma reveals a novel mechanism for cancer cell survival and control of migration.
1/2021	Circular RNA profiling distinguishes medulloblastoma groups and shows aberrant RMST overexpression in WNT medulloblastoma.
1/2021	Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma.
6/2020	YBX1 Indirectly Targets Heterochromatin-Repressed Inflammatory Response-Related Apoptosis Genes through Regulating CBX5 mRNA.
1/2020	Germline Elongator mutations in Sonic Hedgehog medulloblastoma.
12/2019	The long noncoding RNA TP73-AS1 promotes tumorigenicity of medulloblastoma cells.
11/2019	A Sexually Dimorphic Role for STAT3 in Sonic Hedgehog Medulloblastoma.
1/2019	Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse.
1/2019	Identification of CD24 as a marker of Patched1 deleted medulloblastoma-initiating neural progenitor cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc Remke Research Topics

Disease

79	Neoplasms (Cancer) 06/2022 - 05/2008
58	Medulloblastoma 01/2022 - 04/2009
12	Brain Neoplasms (Brain Tumor) 06/2022 - 08/2010
12	Glioblastoma (Glioblastoma Multiforme) 06/2022 - 10/2014
8	Glioma (Gliomas) 02/2022 - 05/2008
7	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 05/2008
6	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2012
6	Primitive Neuroectodermal Tumors (PNET) 01/2017 - 09/2007
5	Ependymoma 01/2016 - 07/2010
3	Carcinogenesis 07/2021 - 04/2012
3	Hypoxia (Hypoxemia) 01/2020 - 01/2016
2	Starvation 06/2022 - 01/2017
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2022
2	Pinealoma (Pineoblastoma) 01/2020 - 09/2012
2	Neuroblastoma 07/2019 - 01/2017
2	Tics (Tic) 01/2019 - 12/2014
2	Diffuse Intrinsic Pontine Glioma 01/2017 - 12/2014
1	Rhabdoid Tumor (Rhabdoid Tumors) 01/2022
1	Fever (Fevers) 01/2020
1	Brain Injuries (Brain Injury) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Meningioma (Meningiomas) 01/2020
1	Muscle Hypotonia (Hypotonia) 01/2020
1	Infantile Spasms (West Syndrome) 01/2020

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2009
18	Biological ProductsIBA 01/2022 - 10/2008
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2009
11	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 09/2007
8	MicroRNAs (MicroRNA)IBA 01/2018 - 04/2009
7	Messenger RNA (mRNA)IBA 02/2022 - 05/2008
7	Pharmaceutical PreparationsIBA 12/2020 - 06/2010
6	Phosphotransferases (Kinase)IBA 10/2018 - 05/2014
4	Long Noncoding RNAIBA 01/2022 - 01/2019
4	Histone Deacetylase InhibitorsIBA 01/2021 - 06/2010
4	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2019 - 12/2013
4	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 08/2016
4	Formaldehyde (Formol)FDA Link 01/2016 - 04/2012
4	ParaffinIBA 01/2016 - 04/2012
3	ChromatinIBA 02/2022 - 12/2015
3	Transcription Factors (Transcription Factor)IBA 02/2022 - 11/2019
3	Histone Deacetylases (Histone Deacetylase)IBA 01/2021 - 06/2010
3	Small Interfering RNA (siRNA)IBA 10/2010 - 05/2008
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 06/2022 - 02/2022
2	Carrier Proteins (Binding Protein)IBA 02/2022 - 10/2014
2	Sirolimus (Rapamycin)FDA Link 02/2022 - 04/2012
2	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2012
2	CytokinesIBA 01/2022 - 01/2020
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 06/2020 - 11/2012
2	ProteomeIBA 01/2020 - 10/2018
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 07/2014
2	AntibodiesIBA 01/2019 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2017 - 01/2014
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2016 - 08/2015
2	Histones (Histone)IBA 12/2015 - 03/2013
2	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 11/2015 - 01/2014
2	Proto-Oncogene Proteins B-rafIBA 11/2011 - 04/2011
1	CateninsIBA 06/2022
1	Glucose (Dextrose)FDA LinkGeneric 06/2022
1	Oncogene Proteins (Oncogene Protein)IBA 06/2022
1	Peptide Initiation Factors (Initiation Factor)IBA 02/2022
1	Staphylococcal Protein A (Protein A)IBA 02/2022
1	PlasticsIBA 01/2022
1	1,4-dihydropyridine (dihydropyridine)IBA 01/2022
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2022
1	Lactate Dehydrogenase 5IBA 01/2022
1	GlutaredoxinsIBA 01/2022
1	ProdrugsIBA 01/2022
1	Dyneins (Dynein)IBA 01/2022
1	Folic Acid AntagonistsIBA 01/2022
1	HydrogelsIBA 05/2021
1	piperlongumineIBA 05/2021
1	Circular RNAIBA 01/2021
1	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2021
1	entinostat (MS 275)IBA 01/2021
1	Antisense RNA (Anti-Sense RNA)IBA 01/2021
1	A-Form DNA (A-DNA)IBA 06/2020
1	Y-Box-Binding Protein 1IBA 06/2020
1	Inflammation MediatorsIBA 01/2020
1	Cathepsin BIBA 01/2020
1	Interferon Type IIBA 01/2020
1	InterferonsIBA 01/2020
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2020
1	LipopolysaccharidesIBA 01/2020
1	Gemcitabine FDA Link 01/2020
1	Kruppel-Like Factor 4IBA 01/2020
1	Nortriptyline (Aventyl)FDA LinkGeneric 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	Interleukin-8B ReceptorsIBA 01/2020
1	InflammasomesIBA 01/2020
1	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 01/2020
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2020
1	temsirolimus FDA Link 01/2020

Therapy/Procedure

39	Therapeutics 06/2022 - 10/2008
12	Drug Therapy (Chemotherapy) 12/2020 - 08/2012
4	Radiotherapy 01/2021 - 10/2013
2	Chemoradiotherapy 06/2022 - 01/2016
2	Craniospinal Irradiation 09/2017 - 01/2016
1	Immunotherapy 01/2022
1	Precision Medicine 07/2021
1	Ligation 01/2020